Laurie Keating
CIK: 0001620743
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 1, 2026KLRS
Kalaris Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
18K shares- - Jun 18, 2026PEPG
PepGen Inc.
Award(A)DirectStock Option (Right to Buy)
34K shares- - Jun 11, 2026IMRX
Immuneering Corp
Award(A)DirectStock Option
33.4K shares- - Jan 1, 2026IMRX
Immuneering Corp
Award(A)DirectStock Option
7.9K shares- - Jun 13, 2025IMRX
Immuneering Corp
Award(A)DirectStock Option
33.4K shares- - Jun 4, 2025PEPG
PepGen Inc.
Award(A)DirectStock Option (Right to Buy)
16K shares- - Jan 1, 2025IMRX
Immuneering Corp
Award(A)DirectStock Option
23.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 1, 2026 |  KLRS Kalaris Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| Jun 18, 2026 |  PEPG PepGen Inc. | Award(A) Stock Option (Right to Buy) | 34,000 | - | - | Direct |
| Jun 11, 2026 |  IMRX Immuneering Corp | Award(A) Stock Option | 33,350 | - | - | Direct |
| Jan 1, 2026 | IMRX Immuneering Corp | Award(A) Stock Option | 7,888 | - | - | Direct |
| Jun 13, 2025 | IMRX Immuneering Corp | Award(A) Stock Option | 33,350 | - | - | Direct |
| Jun 4, 2025 | PEPG PepGen Inc. | Award(A) Stock Option (Right to Buy) | 16,000 | - | - | Direct |
| Jan 1, 2025 | IMRX Immuneering Corp | Award(A) Stock Option | 23,485 | - | - | Direct |
1-7 of 7 transactions
About KEATING LAURIE
KEATING LAURIE (SEC CIK 0001620743) files insider reports with the SEC as Director of Kalaris Therapeutics, Inc. (KLRS), Director of PepGen Inc. (PEPG) and Director of Immuneering Corp (IMRX).
Signal8 holds 8 ownership filings by KEATING LAURIE (1 Form 3, 7 Form 4), filed between Jan 2, 2025 and Aug 3, 2026. Those filings report 7 transactions, from Jan 1, 2025 to Aug 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KEATING LAURIE's filings is in BERKELEY HEIGHTS, NJ.
Recent filings by KEATING LAURIE
- Aug 1, 2026: Grant or award of KLRS derivative securities (Form 4, code A).
- Jun 18, 2026: Grant or award of PEPG derivative securities (Form 4, code A).
- Jun 11, 2026: Grant or award of IMRX derivative securities (Form 4, code A).
- Jan 1, 2026: Grant or award of IMRX derivative securities (Form 4, code A).
- Jun 13, 2025: Grant or award of IMRX derivative securities (Form 4, code A).
Other insiders filing for Kalaris Therapeutics, Inc. (KLRS)
- Vandekop Amy O'Leary, VP, Corporate Controller
- Bayko Liisa Ann, Chief Financial Officer
- Jovan-Embiricos Morana, Director
- Ferrara Napoleone, Director
- Hallal David, Director
- AKKARAJU SRINIVAS, Director